We are live on ! Find out more
LP

LMR Partners Portfolio holdings

AUM $45.4B
1-Year Est. Return 60.68%
This Fund
S&P 500
This Quarter Est. Return
+14.07%
1 Year Est. Return
+60.68%
3 Year Est. Return
+183.94%
5 Year Est. Return
+215.13%
10 Year Est. Return
+663.15%
AUM
$6.45B
AUM Growth
+$725M
Cap. Flow
-$581M
Cap. Flow %
-9%
Top 10 Hldgs %
18%
Holding
1,317
New
227
Increased
165
Reduced
129
Closed
313

Sector Composition

Rank Sector Weight
1 Financials 13.98%
2 Technology 9.11%
3 Energy 6.09%
4 Healthcare 4.57%
5 Utilities 4.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NXDT
801
NexPoint Diversified Real Estate Trust
NXDT
$276M
$200K ﹤0.01%
19,253
+2,401
+14% +$28.4K
ML.WS
802
DELISTED
MoneyLion Inc. Warrants, each whole warrant exercisable 1/30th of a share of Class A common stock at an exercise price of $345.00 per whole share
ML.WS
$199K ﹤0.01%
11,700
-339,300
-97% -$23.3K
LUMN icon
803
Lumen
LUMN
$6.38B
$198K ﹤0.01%
+74,544
New +$301K
OBIO icon
804
Orchestra BioMed
OBIO
$231M
$196K ﹤0.01%
+10,015
New +$116K
BMBL icon
805
Bumble
BMBL
$393M
$196K ﹤0.01%
+10,000
New +$226K
EU
806
enCore Energy
EU
$223M
$190K ﹤0.01%
+83,629
New +$190K
TRDA icon
807
Entrada Therapeutics
TRDA
$226M
$189K ﹤0.01%
+13,023
New +$174K
TERN
808
DELISTED
Terns Pharmaceuticals
TERN
$188K ﹤0.01%
+15,849
New +$151K
DAVEW icon
809
Dave Inc Warrants
DAVEW
$34.2M
$186K ﹤0.01%
30,764
EXFY icon
810
Expensify
EXFY
$173M
$186K ﹤0.01%
22,783
+283
+1% +$2.52K
ASRT
811
DELISTED
Assertio
ASRT
$183K ﹤0.01%
+1,914
New +$144K
ABUS icon
812
Arbutus Biopharma
ABUS
$871M
$182K ﹤0.01%
60,000
CXAIW icon
813
CXApp Inc Warrant
CXAIW
$1.01M
$181K ﹤0.01%
100,000
IMMR icon
814
Immersion
IMMR
$254M
$181K ﹤0.01%
+20,242
New +$153K
LMNR icon
815
Limoneira
LMNR
$245M
$180K ﹤0.01%
+10,814
New +$158K
AFRM icon
816
Affirm
AFRM
$24.2B
$175K ﹤0.01%
+15,569
New +$196K
ARAY icon
817
Accuray
ARAY
$29M
$174K ﹤0.01%
+58,744
New +$160K
BURU.WS
818
DELISTED
Nuburu, Inc. Redeemable Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50
BURU.WS
$171K ﹤0.01%
64,160
NRACW
819
DELISTED
Northern Revival Acquisition Corporation Warrant
NRACW
$171K ﹤0.01%
16,666
WVE icon
820
Wave Life Sciences
WVE
$1.13B
$171K ﹤0.01%
+39,459
New +$181K
FIP icon
821
FTAI Infrastructure
FIP
$482M
$168K ﹤0.01%
56,097
+10,634
+23% +$32.3K
ASUR icon
822
Asure Software
ASUR
$237M
$166K ﹤0.01%
+11,466
New +$135K
ATNM icon
823
Actinium Pharmaceuticals
ATNM
$27.2M
$160K ﹤0.01%
+16,943
New +$179K
OSG
824
DELISTED
Overseas Shipholding Group Inc.
OSG
$160K ﹤0.01%
41,053
+4,153
+11% +$15K
CMCL icon
825
Caledonia Mining Corp
CMCL
$361M
$160K ﹤0.01%
+10,516
New +$147K

Similar funds

LMR Partners's Q1 2023 Portfolio in Review

As of Q1 2023, LMR Partners held 1,317 positions worth $6.45B, up 13% from $5.73B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

LMR Partners withdrew a net $581M in Q1 2023, closing 313 positions and reducing 129 holdings. Its most notable exit was Bank of New York Mellon, an estimated $60M position sold in full.

By sector, the portfolio is most concentrated in Financials at 14% of assets, down from 15% a quarter earlier, followed by Technology and Energy.

Against the trend, LMR Partners opened a new position in AstraZeneca worth $42.7M.

  • LMR Partners's largest Q1 2023 buy was AstraZeneca: 307,414 shares worth $42.7M.
  • LMR Partners added most to First Horizon in Q1 2023, an estimated $77.4M increase.
  • LMR Partners's biggest Q1 2023 reduction was TSMC, cutting an estimated $121M.
  • LMR Partners fully exited Bank of New York Mellon in Q1 2023, selling an estimated $60M.
  • LMR Partners's ten largest holdings make up 18% of its $6.45B portfolio in Q1 2023.
  • LMR Partners opened 227 new positions and closed 313 in Q1 2023.
  • LMR Partners's portfolio value rose 13% quarter-over-quarter to $6.45B.

Based on LMR Partners's 13F filing for Q1 2023, filed 15 May 2023.